RDW

SEC source: 0000899243-20-032398 · doc4.xml · nonDerivative · entry 1

Friedkin Thomas Dan · CIK 0001823073 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,000

F1 · balance_after: Represents Class A ordinary shares underlying 20,000 units, with each unit consisting of one Class A ordinary share and one-half of one warrant, and each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50.

SEC source: 0000899243-20-032397 · doc4.xml · nonDerivative · entry 1

HOBBY PAUL W · CIK 0001092063 · Director · Chief Executive Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 100,000

F1 · balance_after: Represents Class A ordinary shares underlying 100,000 units, with each unit consisting of one Class A ordinary share and one-half of one warrant, and each whole warrant exercisable to purchase one Class A ordinary share at a price of $11.50.

SEC source: 0000899243-20-032396 · doc4.xml · derivative · entry 1

Genesis Park Holdings · CIK 0001823485 · Director · 10% owner · See Remarks

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,292,541

Underlying: Class A ordinary shares · 7,292,541 shares

Expires not disclosed

F1 · shares: Genesis Park Holdings, the reporting person (the "Sponsor"), purchased 7,292,541 warrants, as described in the registrant's registration statement on Form S-1 (File No. 333-249066) (as amended, the "S-1"), in a private placement of warrants at a price of $1.00 per private placement warrant. Each whole private placement warrant is exercisable to purchase one Class A ordinary share at a price of $11.50 per share.

F2 · derivative.exercise_date: The warrants become exercisable on the later of (i) 30 days after the completion of the registrant's initial business combination and (ii) 12 months from the closing of the issuer's initial public offering.

F3 · derivative.expiration_date: The warrants expire 5 years after the completion of the registrant's initial business combination or earlier upon redemption or liquidation, as described in the S-1.

F4 · ownership.direct: Each of the registrant's officers and directors may hold a direct or indirect interest in the Sponsor. Each such person disclaims any beneficial ownership of the reported shares other than to the extent of any pecuniary interest they may have therein, directly or indirectly.

SEC source: 0001567619-20-020435 · doc1.xml · derivative · entry 2

Crescent Park Management, L.P. · CIK 0001629984 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes 2 and 3

Disclosed balance after: 1,195,000

Underlying: Class A Ordinary Shares · 5,000 shares

Expires not disclosed

F1 · security: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F1 · shares: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F1 · price: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F4 · derivative.exercise_date: The warrants will become exercisable on the later of 30 days after the completion of the Issuer's initial business combination and November 27, 2021.

F5 · derivative.expiration_date: The warrants will expire five years after the completion of the Issuer's initial business combination or earlier upon redemption of the warrants or liquidation of the Issuer.

F1 · balance_after: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F2 · ownership.nature: The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.

F3 · ownership.nature: The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.

SEC source: 0001567619-20-020435 · doc1.xml · nonDerivative · entry 1

Crescent Park Management, L.P. · CIK 0001629984 · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · See Notes 2 and 3

Disclosed balance after: 2,390,000

F1 · security: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F1 · price: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F1 · balance_after: The reported securities are included within 10,000 Units of the Issuer sold by the reporting persons for $10.0131 per Unit. Each Unit consists of one Class A ordinary share of the Issuer and one-half of one redeemable warrant entitling the holder to purchase one Class A ordinary share of the Issuer at a price of $11.50 per share. Following the transaction, the reporting persons own 2,390,000 Units.

F2 · ownership.nature: The reporting persons are Crescent Park Management, L.P. ("Crescent Park"), Crescent Park GP, LLC ("Crescent Park GP") and Eli D. Cohen. Crescent Park is the investment adviser of investment funds (the "Funds"), and Crescent Park GP is the general partner of the Funds. Mr. Cohen is the control person of Crescent Park and Crescent Park GP. Crescent Park is filing this report for itself and the other reporting persons. The reporting persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934.

F3 · ownership.nature: The Funds hold the securities reported herein directly for the benefit of their investors. Crescent Park and Crescent Park GP indirectly beneficially own the securities reported herein as the investment adviser and general partner, respectively, of the Funds. Mr. Cohen indirectly beneficially owns the securities reported herein as the control person of Crescent Park and Crescent Park GP. The reporting persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest in them.